The role of the PD-L1 expression and EGFR mutations in the postoperative prognosis of NSCLC and the association of the PD-L1 expression with EGFR mutations has been reported in several previous studies5,6. This evidence concerns the gene CD274 and non-small cell lung carcinoma.